Namrah Khan

558 total citations
9 papers, 444 citations indexed

About

Namrah Khan is a scholar working on Pharmaceutical Science, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Namrah Khan has authored 9 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Namrah Khan's work include Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Namrah Khan is often cited by papers focused on Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Namrah Khan collaborates with scholars based in South Korea, Pakistan and Saudi Arabia. Namrah Khan's co-authors include Alam Zeb, Jin‐Ki Kim, Fawad Ali Shah, Fakhar ud Din, Isra Rana, Muhammad Mohsin Ansari, Ho-Ik Choi, Omer Salman Qureshi, Syed Rizvi and Cheol‐Ho Lee and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Namrah Khan

8 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Namrah Khan South Korea 6 215 176 66 44 34 9 444
Ho-Ik Choi South Korea 9 136 0.6× 145 0.8× 46 0.7× 45 1.0× 22 0.6× 14 346
Isra Rana South Korea 7 150 0.7× 166 0.9× 70 1.1× 69 1.6× 19 0.6× 10 389
Flávia Nathiely Silveira Fachel Brazil 16 153 0.7× 151 0.9× 75 1.1× 37 0.8× 83 2.4× 38 545
Dnyandev Gadhave India 13 285 1.3× 199 1.1× 111 1.7× 59 1.3× 29 0.9× 25 550
Hussein M. Eid Egypt 15 476 2.2× 193 1.1× 137 2.1× 35 0.8× 36 1.1× 24 744
Sattam Khulaif Alenezi Saudi Arabia 11 65 0.3× 130 0.7× 52 0.8× 36 0.8× 13 0.4× 29 360
Soraia Pinto Portugal 11 164 0.8× 122 0.7× 107 1.6× 67 1.5× 34 1.0× 19 441
Adryana Clementino Italy 10 314 1.5× 181 1.0× 116 1.8× 40 0.9× 46 1.4× 13 538
Shaimaa S. Ibrahim Egypt 10 94 0.4× 96 0.5× 64 1.0× 32 0.7× 17 0.5× 16 318

Countries citing papers authored by Namrah Khan

Since Specialization
Citations

This map shows the geographic impact of Namrah Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Namrah Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Namrah Khan more than expected).

Fields of papers citing papers by Namrah Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Namrah Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Namrah Khan. The network helps show where Namrah Khan may publish in the future.

Co-authorship network of co-authors of Namrah Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Namrah Khan. A scholar is included among the top collaborators of Namrah Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Namrah Khan. Namrah Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Khan, Namrah, et al.. (2025). A review of state-of-the-art strategies for encapsulating hydrophilic drugs into lipid nanocarriers. Journal of Pharmaceutical Investigation.
2.
Zeb, Alam, Namrah Khan, Fawad Ali Shah, et al.. (2024). A review on the nanotechnology-based approaches for managing sexually transmitted infections. Journal of Pharmaceutical Investigation. 54(3). 283–316. 3 indexed citations
3.
Choi, Ho-Ik, Fawad Ali Shah, Namrah Khan, et al.. (2024). Core-shell tablets designed for modified and sequential release of ibuprofen and rabeprazole. International Journal of Pharmaceutics. 666. 124839–124839. 3 indexed citations
4.
Choi, Ho-Ik, Alam Zeb, Isra Rana, et al.. (2022). Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs). Journal of Controlled Release. 350. 652–667. 49 indexed citations
5.
Rana, Isra, Namrah Khan, Izhar Ullah, et al.. (2021). Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. International Journal of Pharmaceutics. 603. 120670–120670. 61 indexed citations
6.
Zeb, Alam, Isra Rana, Ho-Ik Choi, et al.. (2020). Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals. Pharmaceutics. 12(12). 1184–1184. 67 indexed citations
7.
Rana, Isra, Namrah Khan, Muhammad Mohsin Ansari, et al.. (2020). Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids and Surfaces B Biointerfaces. 194. 111209–111209. 70 indexed citations
8.
Khan, Namrah, Fawad Ali Shah, Isra Rana, et al.. (2020). Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity. International Journal of Pharmaceutics. 577. 119033–119033. 82 indexed citations
9.
Rizvi, Syed, Fawad Ali Shah, Namrah Khan, et al.. (2019). Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model. International Journal of Pharmaceutics. 560. 136–143. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026